RAF-MEK-ERK pathway in cancer evolution and treatment

R Ullah, Q Yin, AH Snell, L Wan - Seminars in cancer biology, 2022 - Elsevier
Abstract The RAF-MEK-ERK signaling cascade is a well-characterized MAPK pathway
involved in cell proliferation and survival. The three-layered MAPK signaling cascade is …

The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition

S Meloche, J Pouysségur - Oncogene, 2007 - nature.com
The Ras-dependent extracellular signal-regulated kinase (ERK) 1/2 mitogen-activated
protein (MAP) kinase pathway plays a central role in cell proliferation control. In normal cells …

Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets

DW Hommes, MP Peppelenbosch, SJH Van Deventer - Gut, 2003 - gut.bmj.com
Over the last decade important advances have been made in our understanding of the
molecular events underlying cellular responses to extracellular signals. Increased …

A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase

J Ninomiya-Tsuji, T Kajino, K Ono, T Ohtomo… - Journal of Biological …, 2003 - ASBMB
TAK1, a member of the mitogen-activated kinase kinase kinase (MAPKKK) family,
participates in proinflammatory cellular signaling pathways by activating JNK/p38 MAPKs …

Pharmacological inhibitors of MAPK pathways

JM English, MH Cobb - Trends in pharmacological sciences, 2002 - cell.com
Mitogen-activated protein kinases [MAPKs, also called extracellular signal-regulated
kinases (ERKs)] are constituents of numerous signal transduction pathways, and are …

From basic research to clinical development of MEK1/2 inhibitors for cancer therapy

C Frémin, S Meloche - Journal of hematology & oncology, 2010 - Springer
Abstract The Ras-dependent Raf/MEK/ERK1/2 mitogen-activated protein (MAP) kinase
signaling pathway is a major regulator of cell proliferation and survival. Not surprisingly …

Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

CWM Reuter, MA Morgan… - Blood, The Journal of the …, 2000 - ashpublications.org
A series of alterations in the cellular genome affecting the expression or function of genes
controlling cell growth and differentiation is considered to be the main cause of cancer …

[HTML][HTML] Novel host response therapeutic approaches to treat periodontal diseases

KL Kirkwood, JA Cirelli, JE Rogers… - Periodontology …, 2007 - ncbi.nlm.nih.gov
Periodontal disease initiation and progression occurs as a consequence of the host immune
inflammatory response to oral pathogens. Periodontal pathogens produce harmful by …

MEK1/2 inhibitors: molecular activity and resistance mechanisms

PK Wu, JI Park - Seminars in oncology, 2015 - Elsevier
Aberrant activation of the three-layered protein kinase cascade, Raf/MEK/ERK, is often
detected in human cancer, which is mainly attributed to the oncogenic alterations of RAF, or …

Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides

A Schirmer, J Kennedy, S Murli… - Proceedings of the …, 2006 - National Acad Sciences
Resorcylic acid lactones containing a cis-enone are susceptible to Michael addition
reactions and are potent inhibitors of several protein kinases. A structural-bioinformatics …